MCKENZIE KUSGEN: Open Payments
NPI 1619593597 · SEDALIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 15 payments from 7 companies in 2025. Trend: 2023 $319 · 2024 $496 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $93 |
| Amgen Inc. | 4 | $72 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| GENZYME CORPORATION | 1 | $25 |
| PFIZER INC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: LEQVIO, REPATHA, VERQUVO, FABRAZYME, ENTRESTO, ELIQUIS, JARDIANCE, SHINGRIX.
Industry payments across MO — which companies pay providers there.
